| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma. Association of diabetes mellitus and cholangiocarcinoma | Saengboonmee, C. Seubwai, W. Wongkham, C. Wongkham, S. |
2015 | ||||
| 2. | High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation | Saengboonmee, C. Seubwai, W. Pairojkul, C. Wongkham, S. |
2016 | ||||
| 3. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Phoomak, C. Vaeteewoottacharn, K. Silsirivanit, A. Saengboonmee, C. Seubwai, W. Sawanyawisuth, K. Wongkham, C. |
2017 | ||||
| 4. | Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB | Saengboonmee, C. Seubwai, W. Cha'on, U. Sawanyawisuth, K. Wongkham, C. |
2017 | ||||
| 5. | Prognostic biomarkers for cholangiocarcinoma and their clinical implications | Saengboonmee, C. Sawanyawisuth, K. Chamgramol, Y. Wongkham, S. |
2018 | ||||
| 6. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients | Silsirivanit, A. Phoomak, C. Seubwai, W. Saengboonmee, C. Wongkham, S. |
2019 | ||||
| 7. | NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells | Saengboonmee, C. Phoomak, C. Wongkham, C. Seubwai, W. Wongkham, S. |
2020 | ||||
| 8. | Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication | Saengboonmee, C. Seubwai, W. Lert-Itthiporn, W. Wongkham, S. |
2021 | ||||
| 9. | High glucose: an emerging association between diabetes mellitus and cancer progression | Seubwai, W. Wongkham, S. Saengboonmee, C. |
2021 | ||||
| 10. | High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma | Seubwai, W. Phoomak, C. Saengboonmee, C. Wongkham, S. Wongkham, C. |
2021 | ||||
| 11. | Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations | Saengboonmee, C. | 2021 | ||||
| 12. | Repurposing metformin for cancer treatment: A great challenge of a promising drug | Saengboonmee, C. Wongkham, S. |
2021 | ||||
| 13. | The path to destruction for D-type cyclin proteins | Saengboonmee, C. | 2021 | ||||
| 14. | Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract | Zeng, F. Zhou, Y. Khowtanapanich, T. Saengboonmee, C. |
2022 | ||||
| 15. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Saengboonmee, C. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2022 | ||||
| 16. | Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis | Thamrongwaranggoon, U. Seubwai, W. Saengboonmee, C. Wongkham, S. |
2022 | ||||
| 17. | Lepromatous leprosy with a suspected 30-year incubation period: A case report of a practically eradicated area | Julanon, N. Saengboonmee, C. |
2022 | ||||
| 18. | Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer | Saengboonmee, C. | 2022 | ||||
| 19. | THE STRESS AMONG CAREGIVERS OF PATIENTS WITH CHEMOTHERAPY-TREATED CANCER IN NORTHEAST, THAILAND:A CROSS-SECTIONAL STUDY | Saengboonmee, C. Thepchatree, S. Chumwarathayee, C. Bunmas, M. Jumwong, P. Luvira, V. Boonjaraspinyo, S. |
2022 | ||||
| 20. | Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated with Hepatoxic Carcinogen | Chomphoo, S. Kunprom, W. Thithuan, K. Sorin, S. Khawkhiaw, K. Kamkaew, A. Phoomak, C. Chiu, C.F. |
2023 | ||||
| 21. | Revision of potential prognostic markers of cholangiocarcinoma for clinical practice | Saengboonmee, C. Obchoei, S. Sawanyawisuth, K. Wongkham, S. |
2023 | ||||
| 22. | Advancing Age May Decrease Mitochondrial Activity in Cumulus Cells | Jitngamsujarit, S. Salang, L. Saengboonmee, C. Sorin, S. Thithuan, K. Pongsritasana, T. Sukkasame, S. |
2024 | ||||
| 23. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma | Silsirivanit, A. Alvarez, M.R.S. Grijaldo-Alvarez, S.J. Gogte, R. Kitkhuandee, A. Piyawattanametha, N. Seubwai, W. Luang, S. Panawan, O. Mahalapbutr, P. Vaeteewoottacharn, K. Sawanyawisuth, K. Let-Itthiporn, W. Saengboonmee, C. Duangthongphon, P. Jingjit, K. Pankongsap, A. Waraasawapati, S. Aphivatanasiri, C. Lebrilla, C.B. |
2025 | Count | 23 | 0 | 0 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma. Association of diabetes mellitus and cholangiocarcinoma | Saengboonmee, C. Seubwai, W. Wongkham, C. Wongkham, S. |
2015 |
Cancer Epidemiology 3 (39), pp. 274-278 |
||||||||
| 2. | High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation | Saengboonmee, C. Seubwai, W. Pairojkul, C. Wongkham, S. |
2016 |
Scientific Reports (6), pp. |
||||||||
| 3. | High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation | Phoomak, C. Vaeteewoottacharn, K. Silsirivanit, A. Saengboonmee, C. Seubwai, W. Sawanyawisuth, K. Wongkham, C. |
2017 |
Scientific Reports (7), pp. |
||||||||
| 4. | Metformin exerts antiproliferative and anti-metastatic effects against cholangiocarcinoma cells by targeting STAT3 and NF-κB | Saengboonmee, C. Seubwai, W. Cha'on, U. Sawanyawisuth, K. Wongkham, C. |
2017 |
Anticancer Research 1 (37), pp. 115-123 |
||||||||
| 5. | Prognostic biomarkers for cholangiocarcinoma and their clinical implications | Saengboonmee, C. Sawanyawisuth, K. Chamgramol, Y. Wongkham, S. |
2018 |
Expert Review of Anticancer Therapy 6 (18), pp. 579-592 |
||||||||
| 6. | Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients | Silsirivanit, A. Phoomak, C. Seubwai, W. Saengboonmee, C. Wongkham, S. |
2019 |
Glycoconjugate Journal 2 (36), pp. 103-111 |
||||||||
| 7. | NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells | Saengboonmee, C. Phoomak, C. Wongkham, C. Seubwai, W. Wongkham, S. |
2020 |
Life Sciences (262), pp. |
||||||||
| 8. | Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication | Saengboonmee, C. Seubwai, W. Lert-Itthiporn, W. Wongkham, S. |
2021 |
Canadian Journal of Diabetes 3 (45), pp. 282-290 |
||||||||
| 9. | High glucose: an emerging association between diabetes mellitus and cancer progression | Seubwai, W. Wongkham, S. Saengboonmee, C. |
2021 |
Journal of Molecular Medicine 9 (99), pp. 1175-1193 |
||||||||
| 10. | High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma | Seubwai, W. Phoomak, C. Saengboonmee, C. Wongkham, S. Wongkham, C. |
2021 |
Life Sciences (271), pp. |
||||||||
| 11. | Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations | Saengboonmee, C. | 2021 |
Journal of Hepato-Biliary-Pancreatic Sciences 12 (28), pp. 1047-1059 |
||||||||
| 12. | Repurposing metformin for cancer treatment: A great challenge of a promising drug | Saengboonmee, C. Wongkham, S. |
2021 |
Anticancer Research 12 (41), pp. 5913-5918 |
||||||||
| 13. | The path to destruction for D-type cyclin proteins | Saengboonmee, C. | 2021 |
Nature 7856 (592), pp. 690-691 |
||||||||
| 14. | Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract | Zeng, F. Zhou, Y. Khowtanapanich, T. Saengboonmee, C. |
2022 |
In Vivo 4 (36), pp. 1580-1590 |
||||||||
| 15. | High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus | Saengboonmee, C. Sawanyawisuth, K. Seubwai, W. Wongkham, S. |
2022 |
Nutrition and Cancer 5 (74), pp. 1734-1744 |
||||||||
| 16. | Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis | Thamrongwaranggoon, U. Seubwai, W. Saengboonmee, C. Wongkham, S. |
2022 |
Life Sciences (302), pp. |
||||||||
| 17. | Lepromatous leprosy with a suspected 30-year incubation period: A case report of a practically eradicated area | Julanon, N. Saengboonmee, C. |
2022 |
Journal of Taibah University Medical Sciences 4 (17), pp. 602-605 |
||||||||
| 18. | Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer | Saengboonmee, C. | 2022 |
Molecular Metabolism (65), pp. |
||||||||
| 19. | THE STRESS AMONG CAREGIVERS OF PATIENTS WITH CHEMOTHERAPY-TREATED CANCER IN NORTHEAST, THAILAND:A CROSS-SECTIONAL STUDY | Saengboonmee, C. Thepchatree, S. Chumwarathayee, C. Bunmas, M. Jumwong, P. Luvira, V. Boonjaraspinyo, S. |
2022 |
Suranaree Journal of Science and Technology 3 (29), pp. |
||||||||
| 20. | Hyperglycemia Alters O-GlcNAcylation Patterns of Hepatocytes in Mice Treated with Hepatoxic Carcinogen | Chomphoo, S. Kunprom, W. Thithuan, K. Sorin, S. Khawkhiaw, K. Kamkaew, A. Phoomak, C. Chiu, C.F. |
2023 |
In Vivo 2 (37), pp. 685-695 |
||||||||
| 21. | Revision of potential prognostic markers of cholangiocarcinoma for clinical practice | Saengboonmee, C. Obchoei, S. Sawanyawisuth, K. Wongkham, S. |
2023 |
Expert Review of Anticancer Therapy 5 (23), pp. 517-530 |
||||||||
| 22. | Advancing Age May Decrease Mitochondrial Activity in Cumulus Cells | Jitngamsujarit, S. Salang, L. Saengboonmee, C. Sorin, S. Thithuan, K. Pongsritasana, T. Sukkasame, S. |
2024 |
Journal of Clinical Medicine 10 (13), pp. |
||||||||
| 23. | Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma | Silsirivanit, A. Alvarez, M.R.S. Grijaldo-Alvarez, S.J. Gogte, R. Kitkhuandee, A. Piyawattanametha, N. Seubwai, W. Luang, S. Panawan, O. Mahalapbutr, P. Vaeteewoottacharn, K. Sawanyawisuth, K. Let-Itthiporn, W. Saengboonmee, C. Duangthongphon, P. Jingjit, K. Pankongsap, A. Waraasawapati, S. Aphivatanasiri, C. Lebrilla, C.B. |
2025 |
Journal of Proteome Research 3 (24), pp. 1402-1413 |
||||||||
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|